Cancer screening and risk stratification
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- INSTITUT CATALA D'ONCOLOGIA
Spanish cancer research centre specialising in tobacco control, cancer screening programmes, and genomic diagnostics across European consortia.
“4-IN THE LUNG RUN (lung cancer screening), RISCC (cervical cancer screening), and oncNGS (NGS diagnostics) all focus on improving cancer detection through personalised, risk-based approaches.”
PrimaryES14 projects - AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO
Major Turin university hospital contributing clinical data and patient cohorts to European cancer screening and liver disease research.
“Core contributor to EU-TOPIA, MyPeBS, RISCC, and EU-TOPIA-EAST — all focused on improving breast and cervical cancer screening through personalized risk models.”
PrimaryIT8 projects - AGENCE NATIONALE DE SANTE PUBLIQUE
France's national public health agency contributing epidemiological surveillance, biomonitoring data, and population health expertise to European research consortia.
“Partner in MyPeBS, an international randomized study on personalized, risk-based breast cancer screening using genetic polymorphisms and risk scores.”
FR7 projects